Cutaneous metastases - Clinical presentation, histopathology and specific markers;Kutane metastasen - Klinik, histopathologie und spezielle marker

Aktuelle Dermatologie

Volumn 31, Issue 12, 2005, Pages 541-548

  Moll, Ingrid ^a   Moll, R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 7; ESTROGEN RECEPTOR; GROSS CYSTIC DISEASE FLUID PROTEIN 15; KERATIN; PROTEIN; THYROID TRANSCRIPTION FACTOR 1; TUMOR MARKER; UNCLASSIFIED DRUG; VIMENTIN;

ADENOCARCINOMA; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CELL TYPE; CLINICAL EXAMINATION; CLINICAL FEATURE; COLON CANCER; CORRELATION ANALYSIS; DERMIS; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; EPIDERMIS; GRANULOMA; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MORPHOLOGY; OVARY CANCER; RECTUM CANCER; SCALP; SKIN METASTASIS; STOMACH CANCER; THORAX; TUMOR LOCALIZATION; UMBILICAL CORD;

EID: 29244438839     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870502     Document Type: Article

References (31)

1. Moll R, Moll I. Hautmetastasen. In: Remmele W (Hrsg). Pathologie (3. Auflage), Kap. 17, Berlin: Springer, im Druck, 2005
2. Brownstein MH, Helwig EB. Metastatic tumors of the skin. Cancer 1972; 29: 1298-1307
3. Brownstein MH, Helwig EB. Spread of tumors to the skin. Arch Dermatol 1973; 107: 80-86
4. Hödl S, Kerl H. Hautmetastasen viszeraler Karzinome. In: Kerl H, Garbe C, Cerroni L, Wolff HH (Hrsg). Histopathologic der Haut (Kap. 41). Berlin: Springer, 2003: 925-941
5. Weedon D. Skin pathology. Cutaneous metastases. London: Churchill Livingstone, 2002: 1045-1055
6. Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol 1995; 33: 161-182
7. Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J 2003; 96: 164-167
8. Saikia B, Dey P, Saikia UN, Das A. Fine needle aspiration cytology of metastatic scalp nodules. Acta Cytol 2001; 45: 537-541
9. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993; 29: 228-236
10. Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. J Am Acad Dermatol 1990; 22: 19-26
11. Le Doussal V, Zangerle PF, Collette J, Spyratos F, Hacene K, Briere M, Franchimont P, Gest J. Immunhistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000. Eur J Cancer Clin Oncol 1985; 21: 715-725
12. Wick MR, Ockner DM, Mills SE, Ritter JH, Swanson PE. Homologous carcinomas of the breast, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol 1998; 109: 75-84
13. Busam KJ, Tan LK, Granter SR, Kohler S, Junkins-Hopkins J, Berwick M, Rosen PP. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol 1999; 12: 786-793
14. Ormsby AH, Snow JL, Su WP, Goellner JR. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. J Am Acad Dermatol 1995; 32: 711-716
15. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993; 143: 1731-1742
16. Ferlicot S, Vincent-Salomon A, Medioni J, Genin P, Rosty C, Sigal-Zafrani B, Freneaux P, Jouve M, Thiery JP, Sastre-Garau X. Wide metastatic spreading in infiltrating lobular carcinoma of the breast. Eur J Cancer 2004; 40: 336-341
17. Ambrogi V, Nofroni I, Tonini G, Mineo TC. Skin metastases in lung cancer: analysis of a 10-year experience. Oncol Rep 2001; 8: 57-61
18. Schwartz RA. Histopathologic aspects of cutaneous metastatic disease. J Am Acad Dermatol 1995; 33: 649-657
19. Chang YL, Lee YC, Liao WY, Wu CT. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Lung Cancer 2004; 44: 149-157
20. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected monoclonal antibodies. Am J Pathol 1992; 140: 427-447
21. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13: 962-972
22. Kaufmann O, Fietze E, Dietel M. Immunhistochemische Diagnostik bei Karzinommetastasen mit unbekanntem Primärtumor. Pathologe 2002; 23: 183-197
23. Werner M, Becker KF, Keller G, Höfler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 2001; 127: 207-216
24. Cormio G, Capotorto M, Di Vagno G, Cazzolla A, Carriero C, Selvaggi L. Skin metastases in ovarian carcinoma: a report of nine cases and a review of the literature. Gynecol Oncol 2003; 90: 682-685
25. Moll R, Pitz S, Levy R, Weikel W, Franke WW, Czernobilski B. Complexity of expression of intermediate filament proteins, including glial filament protein, in endometrial and ovarian adenocarcinomas. Hum Pathol 1991; 10: 989-1001
26. Qian J, Ramnani DM, Bostwick DG. Immunohistochemistry of kidney tumors. In: Dabbs DJ. Diagnostic immunohistochemistry. New York: Churchill Livingstone, 2002: 474-485
27. Yoskovitch A, Hier MP, Okrainec A, Black MJ, Rochon L. Skin metastases in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2001; 124: 248-252
28. Sheppard MN. Specific marker for pulmonary tumor. Histopathology 2000; 36: 237-276
29. Goessling W, McKee PH, Mayer R. Merkel cell carcinoma. J Clin Oncol 2002; 20: 588-598
30. Moll R, Osborn M, Hartschuh W, Moll I, Mahrle G, Weber K. Variability of Expression and Arrangement of Cytokeratin and Neurofilaments in Cutaneous Neuroendocrine Carcinomas (Merkel Cell Tumors): Immunochemical and Biochemical Analysis of Twelve Cases. Ultrastruct Pathol 1986; 10: 473-495
31. Yaziji H, Gown AM. Immunohistochemical markers of melanocytic tumors. Int J Surg Pathol 2003; 11: 11-15